Cited by 83Virus-based gene therapy researchRNA Interference and Gene DeliveryViral Infectious Diseases and Gene Expression in Insects

Understanding Capsid Assembly and Genome Packaging for Adeno-Associated Viruses

Open access
Bennett, Antonette, Mietzsch, Mario, Agbandje-McKenna, Mavis·2017·Future Virology

Abstract

Adeno-associated viruses (AAVs) are promising therapeutic viral vectors. Their capsid is assembled from viral proteins VP1, VP2 and VP3, aided by an assembly-activating protein, followed by replication protein mediated packaging of their 4.7-kb genome with inverted terminal repeats as packaging signals. To aid improvement of AAV vectors, knowledge of viral determinants of successful capsid assembly and genome packaging is important. We review the current knowledge of these two processes and efforts to overcome limited DNA packaging capacity and limit the packaging of unwanted foreign DNA in vector development. Residues involved in essential capsid assembly and genome packaging interactions cannot be manipulated in vector engineering. This information thus aids strategies to improve vector production and to increase AAV packaging capacity toward improved efficacy of this vector system.

AI snapshot

Written from the paper’s full text.

TL;DR

This review summarizes current knowledge of adeno-associated virus (AAV) capsid assembly and genome packaging, focusing largely on AAV2, and discusses how these processes inform vector engineering. It highlights essential viral determinants, packaging limits, and strategies to overcome them.

Key findings

  • AAV capsids are assembled from 60 subunits of VP1:VP2:VP3 in an approximate 1:1:10 ratio, with T = 1 icosahedral symmetry and a diameter of approximately 260 Å, packaging a linear ssDNA genome of approximately 4.7 kb flanked by approximately 150-nucleotide ITRs.
  • VP3 common sequence is sufficient to assemble capsids when VP1 and VP2 start codons are knocked out, but the assembly-activating protein (AAP) is essential for most tested serotypes except AAV4, AAV5, and AAV11; two- and fivefold interfaces are important for assembly, while the threefold interface appears redundant.
  • Genome packaging requires small Rep proteins (Rep52/40), with large Rep proteins (Rep78/68) needed for replication; packaging is coupled to replication, and ssDNA is translocated 3′ to 5′ through the fivefold channel. Mutations such as T329/T330A and R432A reduce or prevent packaging.
  • Packaging is most efficient for genomes of 4.1–4.9 kb, with an upper threshold at 5.2 kb; self-complementary AAV vectors reduce coding capacity by approximately 50% to about 2.5 kb, while oversized, dual, trans-splicing, and miniaturized gene strategies are used for larger genes.

Methods

  • Narrative review synthesizing published structural, mutational, biochemical, and vector-development studies, with most research conducted on AAV2 and therefore the focus of the review.
  • Evidence drawn from x-ray crystallography and cryo-electron microscopy structures, mutagenesis, pulse-chase experiments, sedimentation analysis, mass spectrometry, and packaging assays; no new experimental data are reported.
  • Main analysis is qualitative synthesis, including tables and figures of residues and interactions involved in capsid assembly and genome packaging.

Limitations

  • The paper states several open questions: the temporal order of dimer and pentamer formation, exact roles of nucleolin and nucleophosmin, the reason for serotype-specific AAP requirements, Rep determinants and capsid footprint, additional host factors, and whether the conserved internal nucleotide-binding pocket affects packaging or stability.
  • Evident from the text: the review is not systematic and is heavily focused on AAV2, limiting generalization to other AAV serotypes; it also relies on cited studies rather than presenting primary data.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2217/fvl-2017-0011

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

21 of 57 cited sources checked · 8 supported · 1 flagged · accuracy not yet measured

  • Premisecitation

    All serotypes tested, with the exception of AAV4, AAV5 and AAV11, require AAP in order to assemble their capsid.

    “In the most recent studies, it has been shown that all serotypes tested, with the exception of AAV4, AAV5 and AAV11, require AAP in order to assemble their capsid [35,39, 45–47].”
    Quote in the paperSubstantial claim3 of 5 sources checked
    • cites [35] Sonntag F, Schmidt K, Kleinschmidt JA. A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc. Natl Acad. Sci. USA 107(22), 10220– 10225 (2010). 20479244 PMC2890453 • The discovery of assembly-activating protein settled a decade-long controversy about which VP is essential for capsid assembly and the identification and characterization of the AAV scaffold protein. source

      The Results and Discussion show that AAP is required for AAV2 capsid assembly. The paper does not establish that all tested serotypes require AAP or identify AAV4, AAV5, and AAV11 as exceptions; its discussion of other serotypes concerns sequence conservation, not assembly requirements. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [39] Naumer M, Sonntag F, Schmidt K Properties of the adeno-associated virus assembly-activating protein. J. Virol 86(23), 13038– 13048 (2012). 23015698 PMC3497687 source
    • cites [45] Earley LF, Powers JM, Adachi K Adeno-associated virus assembly-activating protein is not an essential requirement for capsid assembly of AAV serotypes 4, 5 and 11. J. Virol 85(23), 12686– 12697 (2016). PMC5244341 27852862 source
    • cites [46] Sonntag F, Kother K, Schmidt K The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes. J. Virol 85(23), 12686– 12697 (2011). 21917944 PMC3209379 source

      The paper’s Results report that AAV5-VP3 capsid formation was restored by AAP-5, and its summary explicitly says AAV5 assembly required AAP-5. Thus AAV5 is not an exception to AAP dependence in this source. The paper discusses AAV4 and AAV11 sequence differences but does not test their assembly requirement. (LLM, conf=0.92)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
    • cites [47] Popa-Wagner R, Sonntag F, Schmidt K, King J, Kleinschmidt JA. Nuclear translocation of adeno-associated virus type 2 capsid proteins for virion assembly. J. Gen. Virol 93(Pt 9), 1887– 1898 (2012). 22694902 source
  • Premisecitation

    The cytoplasmic fraction contains VP monomers and oligomers ranging from 10 to 15S, consistent with trimers and pentamers of VP1, VP2 and VP3.

    “Sedimentation sucrose gradient analysis of nuclear and cytoplasmic fractions of an AAV infection demonstrated that the cytoplasmic fraction contains a population of VP monomers and oligomers ranging in size from 10 to 15S consistent with the sedimentation coefficients for trimers and pentamers, respectively, of VP1, VP2 and VP3.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [27] Wistuba A, Weger S, Kern A, Kleinschmidt JA. Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins. J. Virol 69(9), 5311– 5319 (1995). 7636974 PMC189369 source

      The Results (Fig. 3a–b; page not provided) report cytoplasmic VP monomers around 6.5S and a continuous distribution of VP1, VP2 and VP3 oligomers extending to 19S. The distinct 10–15S peak and the tentative pentamer interpretation instead concern nuclear VP2/VP3 oligomers; the paper does not identify cytoplasmic oligomers as trimers and pentamers. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Premisecitation

    Nucleolin and nucleophosmin associate with both VPs and assembled capsids in the nucleoli.

    “Additionally, two nuclear proteins, nucleolin and nucleophosmin [43,44], have been shown to associate with both VPs and assembled capsids in the nucleoli.”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [43] Bevington JM, Needham PG, Verrill KC, Collaco RF, Basrur V, Trempe JP. Adeno-associated virus interactions with B23/Nucleophosmin: identification of sub-nucleolar virion regions. Virology 357(1), 102– 113 (2007). 16959286 PMC1829415 source

      The ‘NPM co-localization with Cap and Rep proteins’ section reports that nucleophosmin (NPM) co-localizes with AAV Cap proteins in nucleoli. The Discussion proposes a model in which Cap proteins assemble there and associate with NPM, but the paper does not establish an association with assembled capsids; it also does not address nucleolin. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [44] Qiu J, Brown KE. A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid. Virology 257(2), 373– 382 (1999). 10329548 source

      The Discussion (page unavailable) describes nucleolin binding to VP1 and VP2 and proposes that it may direct them to the nucleolus. The results section reports nucleolin coimmunoprecipitating with assembled capsids and colocalizing with them in the nucleus, while the Discussion says capsid assembly occurs in the nucleolus. The paper does not demonstrate that both associations occur specifically in the nucleoli; it addresses nucleolin, not the separately cited nucleophosmin. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Premisecitation

    By replacing the D-sequence in one of the flanking ITRs with an unrelated sequence, packaging of genomes with only positive or negative polarity can be achieved.

    “By replacing the D-sequence in one of the flanking ITRs with an unrelated sequence, the packaging of genomes with only positive or negative polarity can be achieved [49].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [49] Ling C, Wang Y, Lu Y Enhanced transgene expression from recombinant single-stranded D-sequence-substituted adeno-associated virus vectors in human cell lines in vitro and in murine hepatocytes in vivo. J. Virol 89(2), 952– 961 (2015). 25355884 PMC4300666 source
  • Premisecitation

    Different types of contaminating DNA sequences, including fragments of the host cell genome from vector production cells, are copackaged with transgenes in AAV vectors.

    “different types of contaminating DNA sequences have been described as being copackaged with the transgenes, including fragments of the host cell genome from the cells that are used during vector production [81].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [81] Levy HC, Bowman VD, Govindasamy L Heparin binding induces conformational changes in Adeno-associated virus serotype 2. J. Struct. Biol 165(3), 146– 156 (2009). 19121398 PMC3694330 source

      The Results and Discussion section ('AAV2-Hep encapsidates an ordered, dodecahedral cage of DNA'; page unavailable) reports non-viral DNA inside AAV2 virus-like particles and suggests that random DNA fragments may be packaged during assembly. It does not identify those fragments as host-cell genomic DNA or show them copackaged with transgenes in AAV vectors; the particles studied lacked a viral genome. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • May combine two claims. 24
  • Classified as probably not a substantial claim. 10
  • May combine two claims.

    Premisecitation

    The virus capsid protects the viral genome, determines tissue tropism, and remains intact while it escapes the endo/lysosomal pathway and traffics to the nucleus where the genome is released.

    “The virus capsid is a critical component of its infectious lifecycle: it protects the viral genome, determines the tissue type that is targeted (tissue tropism) or treated, and remains intact while it escapes the endo/lysosomal pathway and traffics to the nucleus where the genome is released [9]”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [9] Nonnenmacher M, Weber T. Intracellular transport of recombinant adeno-associated virus vectors. Gene Ther. 19(6), 649– 658 (2012). 22357511 PMC4465241 source

      The Introduction (page unavailable) links AAV serotypes to different tissue tropisms, and Cellular Barriers to AAV Transduction and Nuclear Import (pages unavailable) describe escape followed by probable import of intact particles and DNA release after nuclear entry. The paper says the capsid contains the genome, but does not explicitly say it protects it; it also presents intact-particle nuclear import as likely rather than certain. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    The twofold region has the least number of VP-VP interface interactions and represents the thinnest region of the virus capsid shell.

    “This region has the least number of VP–VP interface interactions and represents the thinnest region of the virus capsid shell [23,24].”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [23] Govindasamy L, Padron E, Mckenna R Structurally mapping the diverse phenotype of adeno-associated virus serotype 4. J. Virol 80(23), 11556– 11570 (2006). 16971437 PMC1642620 • One of the main papers describing the structure of the adeno-associated virus (AAV) 4 capsid, comparing it with other serotypes, defining conserved and variable regions between these serotypes and correlating it to the capsid function. source
    • cites [24] Agbandje-Mckenna M, Kleinschmidt J. AAV capsid structure and cell interactions. Methods Mol. Biol 807 47– 92 (2011). 22034026 source
  • May combine two claims.

    Premisecitation

    The threefold protrusions are formed from interdigitating loops from two VPs and have the most extensive VP-VP interactions.

    “These protrusions are formed from interdigitating loops from two VPs and have the most extensive VP–VP interactions [23,24].”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [23] Govindasamy L, Padron E, Mckenna R Structurally mapping the diverse phenotype of adeno-associated virus serotype 4. J. Virol 80(23), 11556– 11570 (2006). 16971437 PMC1642620 • One of the main papers describing the structure of the adeno-associated virus (AAV) 4 capsid, comparing it with other serotypes, defining conserved and variable regions between these serotypes and correlating it to the capsid function. source
    • cites [24] Agbandje-Mckenna M, Kleinschmidt J. AAV capsid structure and cell interactions. Methods Mol. Biol 807 47– 92 (2011). 22034026 source
  • May combine two claims.

    Premisecitation

    Mass spectrometry analysis of AAV1 showed that incorporation of VP1, VP2 and VP3 into the virus capsid was stochastic and likely related to the rate of expression of each VP.

    “More recently, mass spectrometry analysis of AAV1 by an orbitrap mass spectrometer showed that the incorporation of VP1, VP2 and VP3 into the virus capsid was stochastic and likely related to the rate of expression of each VP [30].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [30] Snijder J, van de Waterbeemd M, Damoc E Defining the stoichiometry and cargo load of viral and bacterial nanoparticles by Orbitrap mass spectrometry. J. Am. Chem. Soc 136(20), 7295– 7299 (2014). 24787140 PMC4046769 source
  • May combine two claims.

    Premisecitation

    AAP binds to AAV VP multimers across the twofold axis of symmetry at β strands located at the inner surface of the capsid and targets these VPs to the nucleus where it facilitates capsid assembly.

    “AAP was reported to bind to the AAV VP multimers across the twofold axis of symmetry (thus, a dimer interface) at the β strands located at the inner surface of the capsid and target these VPs to the nucleus where it facilitates capsid assembly [35].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [35] Sonntag F, Schmidt K, Kleinschmidt JA. A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc. Natl Acad. Sci. USA 107(22), 10220– 10225 (2010). 20479244 PMC2890453 • The discovery of assembly-activating protein settled a decade-long controversy about which VP is essential for capsid assembly and the identification and characterization of the AAV scaffold protein. source

      The Results (page unavailable) show that AAP directs VP3 to nucleoli and promotes capsid formation. The Discussion (page unavailable) says the mechanism of AAP-mediated assembly remains elusive; our copy does not establish that AAP binds VP multimers at the twofold-axis dimer interface or at β strands on the capsid’s inner surface. (LLM, conf=0.90)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    During AAV replication, the N-terminus of the large Rep proteins binds specifically to the RBE within the ITRs and cleaves the trs, which allows self-priming and induces further replication.

    “During AAV replication, the N-terminus of the large Rep proteins (Table 2 & Figure 6A) [51] bind specifically to the RBE within the ITRs and cleave the trs [52] which allows self-priming and induces further replication.”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [51] Alex M, Weger S, Mietzsch M, Slanina H, Cathomen T, Heilbronn R. DNA-binding activity of adeno-associated virus Rep is required for inverted terminal repeat-dependent complex formation with herpes simplex virus ICP8. J. Virol 86(5), 2859– 2863 (2012). 22205745 PMC3302247 source
    • cites [52] Im DS, Muzyczka N. Factors that bind to adeno-associated virus terminal repeats. J. Virol 63(7), 3095– 3104 (1989). 2542617 PMC250866 source

      The Abstract identifies Rep78 and Rep68 as possible components of a complex that binds AAV terminal repeats, supporting the reference to the large Rep proteins. It does not locate binding in their N-terminus. The binding and cleavage clause is attached to citation [52], not the citation being audited. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    Residues involved in essential capsid assembly and genome packaging interactions cannot be manipulated in vector engineering.

    “Residues involved in essential capsid assembly and genome packaging interactions cannot be manipulated in vector engineering.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisenone given

    Large Rep proteins Rep78/68 are indispensable for genome replication, while small Rep proteins Rep52/40 are essential for genome packaging.

    “While the large Rep proteins, Rep78/68 are indispensable for genome replication, the small Rep proteins, Rep52/40 are essential for genome packaging.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisenone given

    AAV capsid is assembled from VP1, VP2 and VP3, aided by an assembly-activating protein, followed by replication protein mediated packaging of their 4.7-kb genome with inverted terminal repeats as packaging signals.

    “Their capsid is assembled from viral proteins VP1, VP2 and VP3, aided by an assembly-activating protein, followed by replication protein mediated packaging of their 4.7-kb genome with inverted terminal repeats as packaging signals.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    The AAV capsid is composed of 60 subunits of overlapping VP1:VP2:VP3 in an approximate ratio of 1:1:10, assembled with T=1 icosahedral symmetry and a diameter of approximately 260 Å.

    “The AAV capsid is composed of 60 subunits of the overlapping VP1:VP2:VP3, in an approximate ratio of 1:1:10, assembled with T = 1 icosahedral symmetry and a diameter of approximately 260 Å [13,14].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [13] Chapman MS, Agbandje-Mckenna M. Atomic structure of viral particles.In: Parvoviruses. Bloom ME, Linden RM, Parrish CR, Kerr JR (Eds). Edward Arnold, Ltd, London, UK, 109– 123 (2006).

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [14] Buller RM, Rose JA. Characterization of adenovirus-associated virus-induced polypeptides in KB cells. J. Virol 25(1), 331– 338 (1978). 621779 PMC353931 source
  • May combine two claims.

    Premisecitation

    Capsids colocalize with both Rep proteins and the ssDNA.

    “This is followed by the observation of capsids colocalizing with both Rep proteins and the ssDNA [26, 41–42].”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [26] Wistuba A, Kern A, Weger S, Grimm D, Kleinschmidt JA. Subcellular compartmentalization of adeno-associated virus type 2 assembly. J. Virol 71(2), 1341– 1352 (1997). 8995658 PMC191189 source
    • cites [41] Hunter LA, Samulski RJ. Colocalization of adeno-associated virus Rep and capsid proteins in the nuclei of infected cells. J. Virol 66(1), 317– 324 (1992). 1370086 PMC238290 source
    • cites [42] Bleker S, Pawlita M, Kleinschmidt JA. Impact of capsid conformation and Rep-capsid interactions on adeno-associated virus type 2 genome packaging. J. Virol 80(2), 810– 820 (2006). 16378983 PMC1346863 source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    The AAV VP monomer N-terminus is not seen in crystal structures but has been suggested to be located on the inside of the capsid by cryo-reconstruction.

    “The AAV VP monomer N-terminus (VP1u, VP1/2 common region, and ~15 VP3 N-terminal residues) is not seen in the crystal structures but has been suggested to be located on the inside of the capsid by cryo-reconstruction [21].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [21] Kronenberg S, Bottcher B, Von Der Lieth CW, Bleker S, Kleinschmidt JA. A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini. J. Virol 79(9), 5296– 5303 (2005). 15827144 PMC1082756 source
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    The threefold interface, with its numerous interactions, appears to be redundant in AAV capsid assembly.

    “The threefold interface, with its numerous interactions, appears to be redundant in this process.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Rep expression cassettes driven by the AAV p5 promoter result in significant rep gene copackaging, possibly due to a cryptic RBE in the p5 promoter.

    “Rep expression cassettes, driven by the AAV p5 promoter, have been reported to result in significant rep gene copackaging possibly due to the presence of a cryptic RBE in the p5 promoter [83].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [83] Nony P, Chadeuf G, Tessier J, Moullier P, Salvetti A. Evidence for packaging of rep-cap sequences into adeno-associated virus (AAV) type 2 capsids in the absence of inverted terminal repeats: a model for generation of rep-positive AAV particles. J. Virol 77(1), 776– 781 (2003). 12477885 PMC140600 source
  • May combine two claims.

    Premisenone given

    The channel connects the inside of the viral capsid to the outside and is reported to be the site of genome packaging and uncoating, and VP1u externalization for its PLA2 function required for endo/lysosomal capsid escape en route to the nucleus.

    “The channel connects the inside of the viral capsid to the outside and is reported to be the site of genome packaging and uncoating, and VP1u externalization for its PLA2 function required for endo/lysosomal capsid escape en route to the nucleus.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    Further knowledge of AAV determinants for capsid assembly and genome packaging provides important guides for vector engineering.

    “Further knowledge of AAV determinants for capsid assembly and genome packaging provide important guides for vector engineering.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    The products of replication are DNA genomes of positive and negative polarity that are packaged into AAV virions with equal frequency.

    “The products of the replication are DNA genomes of positive and negative polarity that are packaged into the AAV virions with equal frequency [48].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [48] Mayor HD, Torikai K, Melnick JL, Mandel M. Plus and minus single-stranded DNA separately encapsidated in adeno-associated satellite virions. Science 166(3910), 1280– 1282 (1969). 5350322 source
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given

    Nuclear proteins, particularly nucleolin and nucleophosmin, are involved in AAV capsid assembly.

    “Nuclear proteins, particularly nucleolin and nucleophosmin, are involved in this assembly process, although their exact role requires further elucidation.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Premisenone given

    With respect to genome packaging, the Rep proteins and VPs, particularly the VP3 overlapping sequence, play a role.

    “With respect to genome packaging, the Rep proteins and VPs, particularly the VP3 overlapping sequence, play a role.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given

    Changes in the secondary structure elements of the VPs are likely to cause misfolding and ultimately degradation by the ubiquitin/proteasomal pathway.

    “Changes in the secondary structure elements of the VPs are likely to cause misfolding and ultimately degradation by the ubiquitin/proteasomal pathway.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationreasoning

    This knowledge is particularly useful in efforts to generate vector variants with improved transduction efficiency, improved vector production, and packaging of transgenes with oversized genomes.

    “This is particularly useful in efforts to generate vector variants with the desired phenotypes of improved transduction efficiency in addition to improved vector production and the packaging of transgenes with oversized genomes.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    The pulse-chase experiment by Myers and Carter showed that AAV capsid assembly involves rapid formation of empty capsids from a pool of VPs, followed by the slow rate limiting step of packaging the ssDNA genome into the preformed empty capsid.

    “The first glimpse into the mechanism of AAV capsid assembly was provided by the pulse-chase experiment by Myers and Carter which showed that the process involves the rapid formation of empty capsids from a pool of VPs, followed by the slow rate limiting step of packaging the ssDNA genome into the preformed empty capsid (see next section) [25].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [25] Myers MW, Carter BJ. Assembly of adeno-associated virus. Virology 102(1), 71– 82 (1980). 6245509 • The first and only research to date that has shown that the mechanism of capsid assembly is a two-step process and that the packaging step is rate limiting. source
  • May combine two claims.

    Premisecitation

    AAP is a 23-kDa protein encoded within the ORF of VP2 and VP3, initiated from a non-canonical CTG start codon, and translated in a different reading frame compared with the VP sequence.

    “This 23-kDa protein is also encoded within the ORF of VP2 and VP3, initiated from a non-canonical CTG start codon, and translated in a different reading frame compared with the VP sequence.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationreasoning

    These efforts can avoid the modification of essential residues while nonessential amino acid positions provide sites for engineering.

    “These efforts can avoid the modification of essential residues while nonessential aa positions provide sites for engineering.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisenone given

    The ITRs represent packaging signals and also aid amplification of the DNA genome by a self-primed replication mechanism.

    “These not only represent the packaging signals but also aid the amplification of the DNA genome by a self-primed replication mechanism (Figure 5A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    VP proteins are produced in the cytoplasm and transported to the nucleus, specifically to the nucleoli where capsid assembly occurs.

    “Immunofluorescence and immunoprecipitation experiments have shown that the VP proteins are produced in the cytoplasm and are then transported to the nucleus, specifically to the nucleoli where capsid assembly occurs [26].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [26] Wistuba A, Kern A, Weger S, Grimm D, Kleinschmidt JA. Subcellular compartmentalization of adeno-associated virus type 2 assembly. J. Virol 71(2), 1341– 1352 (1997). 8995658 PMC191189 source
  • May combine two claims.

    Interpretationcitation

    Assembled capsids have been detected in the nucleus in the absence of the replication proteins, suggesting that their presence is not required for assembly.

    “However, assembled capsids have been detected in the nucleus in the absence of the replication proteins suggesting that their presence is not required for assembly.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationnone given

    Efficient capsid assembly and genome packaging are essential steps in wild-type AAV infection and in the production of vectors for therapeutic application.

    “Efficient capsid assembly and genome packaging are essential steps in WT virus infection as well as the production of vectors for therapeutic application.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisenone given

    The AAV packaging process occurs in the nucleus of the cell producing the AAV capsid and relies on the presence of assembled empty capsids, replicated AAV genomes and the viral Rep proteins.

    “The AAV packaging process occurs in the nucleus of the cell producing the AAV capsid and relies on the presence of: assembled empty capsids, replicated AAV genomes and the viral Rep proteins.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    To construct rAAVs, only the flanking cis-active ITRs have to be retained for packaging of the transgene cassette while the rep and cap genes can be supplied in trans.

    “To construct rAAVs, only the flanking cis-active ITRs have to be retained for the packaging of the transgene cassette while the rep and cap genes can be supplied in trans [10].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [10] Gray JT, Zolotukhin S. Design and construction of functional AAV vectors. Methods Mol. Biol 807, 25– 46 (2011). 22034025 source
30 of 30
  • The paper relies on this without support.

    The packaging mechanisms of wild-type AAV capsids and recombinant AAV capsids are identical.

    “Generally, it is believed that the packaging mechanisms of both types of AAV capsids are identical.”
  • The paper relies on this without support.

    Contamination of AAV capsids with foreign DNA sequences is detrimental for clinical applications.

    “For the clinical applications of AAV vectors, the capsids should ideally only contain the desired vector genome cassettes with none to minimal contaminations with foreign DNA sequences.”
2 of 2

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Two different papers have identical journal volume, issue, and pages

    Minor

    References 45 and 46 assign the same journal volume, issue, and page range to different articles, with different publication years. Both citations cannot be correct as printed.

1 of 1

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. 10.1016/j.jsb.2014.03.020 · DOI

Cited by

Sorted by citations

Authors
Bennett, A., Mietzsch, M., & Agbandje-McKenna, M.
Affiliations
  • University of Florida (US)
  • Department of Biochemistry & Molecular Biology Center for Structure Biology McKnight Brain Institute University of Florida Gainesville FL 32610-0245 USA
Venue
Future Virology
Published
2017-06
Volume
12
Issue
6
Pages
283-297
ISSN
  • 1746-0794 (ISSN-L)
  • 1746-0808
OpenAlex
W2623463662
Cited by
82
References
85
Citations by year
2026: 17 · 2025: 27 · 2024: 18 · 2023: 6 · 2022: 4 · 2021: 5 · 2020: 4 · 2019: 1
FWCI
0.91
Type
journal article
Language
en
Open access
Locations
  • Future Virology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5r01gm082946-15)
  • National Institute of General Medical Sciences (R01GM109524, R01 GM-082946)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
Keywords
adeno-associated virus, capsid assembly, genome packaging, adeno-associated virus vectors, VP1, VP2, VP3, inverted terminal repeats, packaging capacity, vector engineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-28.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-28.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review